Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Renalytix Plc Share Price
  4. Renalytix Plc Share Regulatory News
  5. Total Voting Rights

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Renalytix Plc Information

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: -2.00 (-9.30%)
Spread: 1.00 (5.263%)
Open: 20.00
High: 20.00
Low: 19.50
Prev. Close: 21.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

31 Jul 2020 16:31

RNS Number : 8003U
Renalytix AI PLC
31 July 2020
 

 

 

Renalytix AI plc

(the "Company") 

 

Total Voting Rights

 

For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following:

 

As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each ("Ordinary Shares"), with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. The total number of voting rights in the Company is therefore 72,029,634.

 

The above figure of 72,029,634 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Renalytix AI plc 

www.renalytixai.com

James McCullough, CEO

Via Walbrook PR

Stifel (Nominated Adviser)

Tel: 020 7710 7600

Alex Price / Nicholas Moore

Walbrook PR Limited

Tel: 020 7933 8780 or renalytix@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRFFLFXBDLEBBL
12345678910
Date   Source Headline
30th Jul 20214:25 pmRNSDirector/PDMR Dealing
28th Jul 20217:00 amRNSAppointment of Ann Berman to Board of Directors
23rd Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSVP of Global Quality and Regulatory Appointment
19th Jul 20213:02 pmRNSExercise of Options and TVR
7th Jul 20217:00 amRNSExercise of options, PDMR transaction and TVR
1st Jul 20213:51 pmRNSDirectorate Change
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 202111:50 amRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSNew data for KidneyIntelX
25th Jun 20215:25 pmRNSDirector/PDMR Dealing
25th Jun 202112:52 pmRNSExercise of options
24th Jun 20212:00 pmRNSChange of name
22nd Jun 20211:25 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 202110:57 amRNSDirector/PDMR Shareholding
15th Jun 20217:00 amRNSFinancial Results for Third Quarter of FY 2021
10th Jun 20217:00 amRNSNotice of Results & Change of Auditor
7th Jun 20217:00 amRNSKey new hires to drive commercialization strategy
3rd Jun 20217:00 amRNSUtility Study
25th May 20217:00 amRNSDirector/PDMR Shareholding
21st May 20217:02 amRNSDirector/PDMR Dealing
19th May 20218:00 amRNSPartnership
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 202111:05 amRNSSecond Price Monitoring Extn
22nd Apr 202111:00 amRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNS10-year US Government contract award
20th Apr 20217:00 amRNSPositive clinical outcome data for KidneyIntelX
19th Apr 20217:00 amRNSDirector/PDMR Shareholding
14th Apr 20217:00 amRNSExclusive option agreement
8th Apr 20217:00 amRNSClinical Utility Study
6th Apr 20217:00 amRNSClinical findings published in Diabetologia
15th Mar 20217:00 amRNSUpdate on Finalization of MCIT Rule
4th Mar 20216:00 pmRNSIssue of shares, PDMR Dealing and TVR
2nd Mar 20217:02 amRNSFinancial Results for Second Quarter of FY 2021
2nd Mar 20217:00 amRNSHalf-year Report
24th Feb 20217:00 amRNSUniversity of Utah Kidney Health Partnership
23rd Feb 20217:00 amRNSNotice of Results
4th Feb 20217:00 amRNSASN & Renalytix to Co-Host Capital Markets Day
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSFinalization of MCIT rule for coverage pathway
5th Jan 20214:41 pmRNSSecond Price Monitoring Extn
5th Jan 20214:36 pmRNSPrice Monitoring Extension
5th Jan 20217:00 amRNSPartnership Between RenalytixAI and DaVita
4th Jan 20217:00 amRNSRENX to present at 39th JP Morgan Healthcare Conf.
7th Dec 20203:45 pmRNSResult of AGM
2nd Dec 20201:08 pmRNSPartnership with National Kidney Foundation
26th Nov 20207:01 amRNSHolding(s) in Company
26th Nov 20207:00 amRNSSale of shares in Renalytix AI plc
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.